^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Peripheral T-cell Lymphoma |
| Drug: | bortezomib (Proteasome inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Peripheral T-cell Lymphoma: Second-line or initial palliative intent therapy (no intention to transplant) and subsequent therapy...Other recommended regimens…Bortezomib (category 2B)